In a retrospective study of 250 outpatients who experience chronic non-cancer pain, there were sex differences in methylation of the promoter region the μ-opioid receptor 1 gene OPRM1 which was significantly correlated to lower rates of OUD in females (24). Here, OPRM1 is linked to cancer.